The drive by African governments to reverse the current inadequate access to medicines is gaining momentum, as governments in the region announce new partnerships with pharmaceutical companies and development partners to scale up investment in the manufacturing of pharmaceutical products with more focus on vaccines. Increasing pharmaceutical manufacturing in Africa would not only reduce dependence on imported human medicines, now estimated at 94% of the continent’s requirements, but would sca...